全文获取类型
收费全文 | 30223篇 |
免费 | 2456篇 |
国内免费 | 995篇 |
专业分类
耳鼻咽喉 | 153篇 |
儿科学 | 540篇 |
妇产科学 | 303篇 |
基础医学 | 8803篇 |
口腔科学 | 429篇 |
临床医学 | 2407篇 |
内科学 | 4860篇 |
皮肤病学 | 896篇 |
神经病学 | 971篇 |
特种医学 | 282篇 |
外国民族医学 | 12篇 |
外科学 | 3607篇 |
综合类 | 3934篇 |
现状与发展 | 5篇 |
预防医学 | 923篇 |
眼科学 | 209篇 |
药学 | 1700篇 |
2篇 | |
中国医学 | 499篇 |
肿瘤学 | 3139篇 |
出版年
2024年 | 27篇 |
2023年 | 262篇 |
2022年 | 320篇 |
2021年 | 716篇 |
2020年 | 628篇 |
2019年 | 758篇 |
2018年 | 728篇 |
2017年 | 753篇 |
2016年 | 812篇 |
2015年 | 1080篇 |
2014年 | 1664篇 |
2013年 | 1830篇 |
2012年 | 1527篇 |
2011年 | 2253篇 |
2010年 | 1956篇 |
2009年 | 2139篇 |
2008年 | 1881篇 |
2007年 | 1926篇 |
2006年 | 1819篇 |
2005年 | 1546篇 |
2004年 | 1456篇 |
2003年 | 1267篇 |
2002年 | 1051篇 |
2001年 | 804篇 |
2000年 | 684篇 |
1999年 | 595篇 |
1998年 | 571篇 |
1997年 | 441篇 |
1996年 | 432篇 |
1995年 | 438篇 |
1994年 | 344篇 |
1993年 | 255篇 |
1992年 | 151篇 |
1991年 | 138篇 |
1990年 | 69篇 |
1989年 | 44篇 |
1988年 | 23篇 |
1987年 | 14篇 |
1985年 | 24篇 |
1984年 | 31篇 |
1983年 | 26篇 |
1982年 | 25篇 |
1981年 | 28篇 |
1980年 | 16篇 |
1979年 | 18篇 |
1977年 | 13篇 |
1976年 | 23篇 |
1975年 | 13篇 |
1974年 | 16篇 |
1973年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
11.
12.
Phonphimon Wongthida Matthew R Schuelke Christopher B Driscoll Timothy Kottke Jill M Thompson Jason Tonne Cathy Stone Amanda L Huff Cynthia Wetmore James A Davies Alan L Parker Laura Evgin Richard G Vile 《Neuro-oncology》2020,22(12):1757
BackgroundDiffuse midline glioma, formerly DIPG (diffuse intrinsic pontine glioma), is the deadliest pediatric brainstem tumor with median survival of less than one year. Here, we investigated (i) whether direct delivery of adenovirus-expressing cluster of differentiation (CD)40 ligand (Ad-CD40L) to brainstem tumors would induce immune-mediated tumor clearance and (ii) if so, whether therapy would be associated with a manageable toxicity due to immune-mediated inflammation in the brainstem.MethodsSyngeneic gliomas in the brainstems of immunocompetent mice were treated with Ad-CD40L and survival, toxicity, and immune profiles determined. A clinically translatable vector, whose replication would be tightly restricted to tumor cells, rAd-Δ24-CD40L, was tested in human patient–derived diffuse midline gliomas and immunocompetent models.ResultsExpression of Ad-CD40L restricted to brainstem gliomas by pre-infection induced complete rejection, associated with immune cell infiltration, of which CD4+ T cells were critical for therapy. Direct intratumoral injection of Ad-CD40L into established brainstem tumors improved survival and induced some complete cures but with some acute toxicity. RNA-sequencing analysis showed that Ad-CD40L therapy induced neuroinflammatory immune responses associated with interleukin (IL)-6, IL-1β, and tumor necrosis factor α. Therefore, to generate a vector whose replication, and transgene expression, would be tightly restricted to tumor cells, we constructed rAd-Δ24-CD40L, the backbone of which has already entered clinical trials for diffuse midline gliomas. Direct intratumoral injection of rAd-Δ24-CD40L, with systemic blockade of IL-6 and IL-1β, generated significant numbers of cures with readily manageable toxicity.ConclusionsVirus-mediated delivery of CD40L has the potential to be effective in treating diffuse midline gliomas without obligatory neuroinflammation-associated toxicity. 相似文献
13.
背景与目的:结直肠癌(colorectal cancer,CRC)为世界第三常见恶性肿瘤,近年来研究者认为白细胞介素(interleukin,IL)-35和(或)IL-37与CRC的发展有关,但其作用机制尚未阐明。探究IL-35和IL-37在CRC发展中的作用及其可能的机制,分析IL-35和IL-37与CRC患者预后的相关性。方法:收集2013年—2017年在上海交通大学医学院附属同仁医院接受治疗的191例CRC患者手术病理蜡块的肿瘤组织,与其匹配的非癌组织是来源于同一患者的肠癌手术切缘蜡块组织。应用免疫组织化学(immunohistochemistry,IHC)染色法将CRC患者的癌组织与非癌组织染色,并运用Image-Pro Plus将IHC染色阳性部分定量分析,结合随访结果,探讨癌组织与非癌组织中IL-35和IL-37的表达水平与CRC临床病理学特征及预后的相关性。结果:与非癌组织相比,CRC组织中IL-35的表达量减少了50%(P<0.000 1)。CRC组织中IL-37的表达量与非癌组织相比增加了40%(P=0.012)。多因素生存分析显示,癌组织中IL-35(HR=0.39;95% CI:0.16~0.97;P=0.04)的表达水平是CRC患者术后生存的独立预测指标。结论:IL-35和IL-37蛋白的表达水平可能与CRC的发展有关,IL-35的表达水平可能是CRC患者术后生存的独立预测指标。 相似文献
14.
CD2AP inhibits metastasis in gastric cancer by promoting cellular adhesion and cytoskeleton assembly
Wangkai Xie Chao Chen Zheng Han Jingjing Huang Xin Liu Hongjun Chen Teming Zhang Sian Chen Chenbin Chen Mingdong Lu Xian Shen Xiangyang Xue 《Molecular carcinogenesis》2020,59(4):339-352
Diffuse gastric cancer (DGC) is a lethal malignancy lacking effective systemic therapy. Among the most provocative recent results in DGC has been that the alter of the cellular cytoskeleton and intercellular adhesion. CD2-associated protein (CD2AP) is one of the critical proteins regulating cytoskeleton assembly and intercellular adhesion. However, no study has investigated the expression and biological significance of CD2AP in gastric cancer (GC) to date. Therefore, the aim of our study was to explore if the expression of CD2AP is associated with any clinical features of GC and to elucidate the underlying mechanism. Immunohistochemistry of 620 patient tissue samples indicated that the expression of CD2AP is downregulated in DGC. Moreover, a low CD2AP level was indicative of poor patient prognosis. In vitro, forced expression of CD2AP caused a significant decrease in the migration and invasion of GC cells, whereas depletion of CD2AP had the opposite effect. Immunofluorescence analysis indicated that CD2AP promoted cellular adhesion and influenced cell cytoskeleton assembly via interaction with the F-actin capping protein CAPZA1. Overall, the upregulation of CD2AP could attenuate GC metastasis, suggesting CD2AP as a novel biomarker for the prognosis and treatment of patients with GC. 相似文献
15.
16.
17.
Eriko Yanagida Hiroaki Miyoshi Mai Takeuchi Noriaki Yoshida Kazutaka Nakashima Kyohei Yamada Takeshi Umeno Yasumasa Shimasaki Takuya Furuta Masao Seto Koichi Ohshima 《Hematological oncology》2020,38(5):680-688
The interaction of CD47 and signal-regulatory protein alpha (SIRPα) induces “don't eat me signal”, leading suppression of phagocytosis. This signal can affect the clinical course of malignant disease. Although CD47 and SIRPα expression are associated with clinicopathological features in several neoplasms, the investigation for adult T-cell leukemia/lymphoma (ATLL) has not been well-documented. This study aimed to declare the association between CD47 and SIRPα expression and clinicopathological features in ATLL. We performed immunostaining on 73 biopsy samples and found that CD47 is primarily expressed in tumor cells, while SIRPα is expressed in non-neoplastic stromal cells. CD47 positive cases showed significantly higher FoxP3 (P = .0232) and lower CCR4 (P = .0214). SIRPα positive cases presented significantly better overall survival than SIRPα negative cases (P = .0132). SIRPα positive cases showed significantly HLA class I (P = .0062), HLA class II (P = .0133), microenvironment PD-L1 (miPD-L1) (P = .0032), and FoxP3 (P = .0229) positivity. In univariate analysis, SIRPα expression was significantly related to prognosis (Hazard ratio [HR] 0.470; 95% confidence interval [CI] 0.253-0.870; P = .0167], although multivariate analysis did not show SIPRα as an independent prognostic factor. The expression of SIRPα on stromal cells reflects activated immune surveillance mechanism in tumor microenvironment and induce good prognosis in ATLL. More detailed studies for gene expression or genomic abnormalities will disclose clinical and biological significance of the CD47 and SIRPα in ATLL. 相似文献
18.
19.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
20.
Johannes Brettschneider Axel Petzold Sigurd D Süssmuth Georg B Landwehrmeyer Albert C Ludolph Jan Kassubek Hayrettin Tumani 《Movement disorders》2006,21(12):2224-2227
We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH(SMI35) in the laboratory-supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple-system atrophy (MSA; n = 21), progressive supranuclear palsy (PSP; n = 21), corticobasal degeneration (CBD; n = 6), and age-matched controls (n = 45) were included. CSF levels of NfH(SMI35) were measured using ELISA. Levels of CSF NfH(SMI35) were elevated in PSP compared to PD and controls (P < 0.05 each). They were also significantly higher in MSA than in PD and controls (P < 0.05 each). NfH(SMI35) differentiated PD from PSP with a sensitivity of 76.5% and a specificity of 94.4%. Axonal damage as measured by CSF NfH(SMI35) is most prominent in the more rapidly progressive syndromes PSP and MSA as compared to PD or CBD. CSF NfH(SMI35) may therefore be of some value for the laboratory-supported differential diagnosis of atypical parkinsonian syndromes. 相似文献